ECA-HPV App for Human Papillomavirus
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the ECA-HPV App treatment for human papillomavirus?
Is the ECA-HPV App safe for humans?
How does the ECA-HPV App treatment differ from other HPV treatments?
The ECA-HPV App treatment is unique because it likely involves a digital or app-based approach to managing HPV, which is different from traditional treatments like vaccines or medications. This app-based method may focus on education, monitoring, or supporting immune responses, offering a novel way to complement existing HPV prevention and treatment strategies.311121314
What is the purpose of this trial?
The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.
Research Team
Michael Paasche-Orlow, MD, MPH
Principal Investigator
Tufts Medical Center
Eligibility Criteria
This trial is for individuals dealing with warts or human papillomavirus (HPV). The study aims to include a diverse group of participants, but specific eligibility criteria are not provided in the information given.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline surveys using REDCap
Intervention
Participants use the ECA-HPV app and complete surveys after well child visits
Follow-up
Participants are monitored for HPV vaccination series completion and satisfaction with the intervention
Treatment Details
Interventions
- ECA-HPV App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tufts Medical Center
Lead Sponsor
Boston Medical Center
Collaborator
Northeastern University
Collaborator